Evidence map›Paper›PMID 23239844›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2013

Nicotine delivery to rats via lung alveolar region-targeted aerosol technology produces blood pharmacokinetics resembling human smoking.

Xuesi M Shao, Bin Xu, Jing Liang, Xinmin Simon Xie, Yifang Zhu, Jack L Feldman

Open access · bronzeAbstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover Study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Potential Harm of IQOS Smoke to Rat Liver.International journal of molecular sciences · 2023
    Article
  7. Assessment of Abuse-Related Discriminative Stimulus Effects of Nicotine Aerosol in Rodents.The Journal of pharmacology and experimental therapeutics · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Pod-mod vs. conventional e-cigarettes: nicotine chemistry, pH, and health effects.Journal of applied physiology (Bethesda, Md. : 1985) · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Acute pulmonary effects of aerosolized nicotine.American journal of physiology. Lung cellular and molecular physiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xuesi M ShaoDepartment of Neurobiology, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, CA 90095, USA. mshao@ucla.edu
Bin Xu
Jing Liang
Xinmin Simon Xie
Yifang Zhu
Jack L Feldman
University of California, Los Angeles · USAfaSci (United States) · US

Funding

RESPIRATORY PATTERN GENERATION STUDIED IN VITROR01HL040959 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FELDMAN, JACK L · 1988 to 2016
$5.9M
Nicotine delivery to rodent with lung alveolar region-targeted aerosol technologyR44DA031578 · NIDA · AFASCI, INC. · PI SHAO, XUESI MAX, XIE, XINMIN SIMON · 2013 to 2014
$991k
Nicotine delivery to rodents with lung alveolar region-targeted aerosol techR43DA031578 · NIDA · AFASCI, INC. · PI SHAO, XUESI MAX, XIE, XINMIN SIMON · 2011 to 2011
$240k
NHLBI NIH HHS R01 HL040959NIDA NIH HHS 1R43DA031578NIDA NIH HHS R43 DA031578NIDA NIH HHS R44 DA031578
6 · The paper itself

Abstract

introductionNicotine is a heavily used addictive drug acquired through smoking tobacco. Nicotine in cigarette smoke is deposited and absorbed in the lungs, which results in a rapidly peaked slowly declining arterial concentration. This pattern plays an important role in initiation of nicotine addiction.

methodsA method and device were developed for delivering nicotine to rodents with lung alveolar region-targeted aerosol technology. The dose of delivery can be controlled by the nicotine aerosol concentration and duration of exposure.

resultsOur data showed that, in the breathing zone of the nose-only exposure chamber, the aerosol droplet size distribution was within the respirable diameter range. Rats were exposed to nicotine aerosol for 2 min. The arterial blood nicotine concentration reached 43.2 ± 15.7 ng/ml (mean ± SD) within 1-4 min and declined over the next 20 min, closely resembling the magnitude and early pharmacokinetics of a human smoking a cigarette. The acute inhalation toxicity of nicotine: LC50 = 2.3mg/L was determined; it was affected by pH, suggesting that acidification decreases nicotine absorption and/or bioavailability.

conclusionsA noninvasive method and toolkit were developed for delivering nicotine to rodents that enable rapid delivery of a controllable amount of nicotine into the systemic circulation and brain-inducing dose-dependent pharmacological effects, even a lethal dose. Aerosol inhalation can produce nicotine kinetics in both arterial and venous blood resembling human smoking. This method can be applied to studies of the effects of chronic intermittent nicotine exposure, nicotine addiction, toxicology, tobacco-related diseases, teratogenicity, and for discovery of pharmacological therapeutics.

Indexed as

Administration, InhalationAerosolsAnimalsDrug Delivery SystemsEquipment DesignHumansLethal Dose 50MaleNicotinePulmonary AlveoliRatsRats, Sprague-DawleySmokingAerosolsNicotine

Identifiers

PMID23239844
PMCPMC3682843
OpenAlexW1987512593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.